Scandmedical Soldk 040 Stock Probability Of Bankruptcy
| K41 Stock | 0.79 0.02 2.47% |
SCANDMEDICAL |
SCANDMEDICAL SOLDK 040 Company chance of financial distress Analysis
SCANDMEDICAL SOLDK-040's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current SCANDMEDICAL SOLDK-040 Probability Of Bankruptcy | Less than 10% |
Most of SCANDMEDICAL SOLDK-040's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SCANDMEDICAL SOLDK 040 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of SCANDMEDICAL SOLDK-040 probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting SCANDMEDICAL SOLDK-040 odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of SCANDMEDICAL SOLDK 040 financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, SCANDMEDICAL SOLDK 040 has a Probability Of Bankruptcy of 10.0%. This is 76.9% lower than that of the Healthcare sector and 75.71% lower than that of the Medical Devices industry. The probability of bankruptcy for all Germany stocks is 74.89% higher than that of the company.
SCANDMEDICAL Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SCANDMEDICAL SOLDK-040's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SCANDMEDICAL SOLDK-040 could also be used in its relative valuation, which is a method of valuing SCANDMEDICAL SOLDK-040 by comparing valuation metrics of similar companies.SCANDMEDICAL SOLDK is currently under evaluation in probability of bankruptcy category among its peers.
About SCANDMEDICAL SOLDK-040 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SCANDMEDICAL SOLDK 040's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SCANDMEDICAL SOLDK-040 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SCANDMEDICAL SOLDK 040 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in SCANDMEDICAL Stock
SCANDMEDICAL SOLDK-040 financial ratios help investors to determine whether SCANDMEDICAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDMEDICAL with respect to the benefits of owning SCANDMEDICAL SOLDK-040 security.